Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing - sprookjes - yvandenbroek - TriplyDB

Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing

Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing

http://www.wikidata.org/entity/Q33967341

about

Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2 Progress and prospects for L2-based human papillomavirus vaccines Prophylactic HPV vaccination: past, present, and future.Novel Approaches for Vaccination Against HPV-Induced Cancers.A novel candidate MS2 phage VLP vaccine displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice.

P2860

Q28603888-BB42F1E4-CFAD-4DF2-AEC1-581CCDACB98A Q35744303-39467A43-1F98-4B4A-93FA-B381124C9DC9 Q37014047-444A088D-5E6A-4F81-B042-6FF7307F9EFA Q38597567-1577274E-5AD9-46DD-A79B-8EAA99E66A00 Q39033362-7C3B3D60-4280-4A99-AB17-9F817F92838F Q41931899-E09752DA-2BBF-4829-8CD9-FB74AD8DDDAE Q55215825-DE399DF2-95B8-4CEB-88B7-E4B268A242AF

P2860

Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing

http://www.wikidata.org/entity/Q33967341

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Immunization with a consensus ...... that are broadly neutralizing

@ast

Immunization with a consensus ...... that are broadly neutralizing

@en

type

label

Immunization with a consensus ...... that are broadly neutralizing

@ast

Immunization with a consensus ...... that are broadly neutralizing

@en

prefLabel

Immunization with a consensus ...... that are broadly neutralizing

@ast

Immunization with a consensus ...... that are broadly neutralizing

@en

P1433

Q33967341-69957978-2667-448D-A735-1B729B720121

P1476

Q33967341-585890EB-292B-4FC2-8EF1-6B3253ECB5BA

P2093

Q33967341-0B67C0F3-CD95-4309-8A4E-0D4E30F72794

Q33967341-1CFE7AB0-8421-43EC-AC44-6212AB8FBDDA

Q33967341-A37B60B9-A657-4426-B787-74280F638FAE

Q33967341-D9267F43-68CC-4517-B249-EF5E557BBD24

Q33967341-D9773E80-FC1B-44FF-8C64-3EAED286A859

P2860

Q33967341-0297298B-D29B-4511-A594-A098EE9A6AC8

Q33967341-04B22684-93C2-4850-B909-F18237618B9F

Q33967341-077C47AC-C547-4D60-A893-B143F1DF3E67

Q33967341-0B4D2A54-B378-44D2-B142-12891B5A254E

Q33967341-1AD0B7AB-6B7B-437B-A2D0-BC81A70AB554

Q33967341-2071DCA0-1A2F-46D0-A9A2-6DA20E4A6238

Q33967341-2EA40E57-8FE3-4CD4-AC05-9C69E7B4AF68

Q33967341-300647D8-D595-48F8-BC48-D3B9C8A7B759

Q33967341-331AECE1-7CA8-4F6F-A979-DF756C42F412

Q33967341-370213E5-B687-4282-B081-9989F6162CCB

P304

Q33967341-2749A4D3-F855-445C-AA9C-5A8C5645710C

P31

Q33967341-54E14634-E546-4A49-BA2C-99F352A177BF

P356

Q33967341-BDBBDEA2-7A5B-4B33-A848-26751DF2AC75

P407

Q33967341-DCBC0D99-73CC-49F9-B237-5A8D9F68B47E

P433

Q33967341-2824AFA2-2458-441F-B9C6-42286EDDFA37

P478

Q33967341-C67AFFED-7B85-4D27-8974-18289F867E1D

P50

Q33967341-FC05FB47-9699-4608-932D-4949B016D2E0

P577

Q33967341-47E723FF-F33D-44FE-B770-3D10027716F2

P698

Q33967341-63746515-0DB5-4601-B9B4-51DE85A4F871

P932

Q33967341-DF3A05E8-46E5-4407-B424-71AD509596E6

P356

J.VACCINE.2014.06.054

P1433

P1476

Immunization with a consensus ...... that are broadly neutralizing

@en

P2093

Agnieszka Dziduszko

http://www.w3.org/2001/XMLSchema#string

Bryce Chackerian

http://www.w3.org/2001/XMLSchema#string

David S Peabody

http://www.w3.org/2001/XMLSchema#string

Ebenezer Tumban

http://www.w3.org/2001/XMLSchema#string

Mitchell Tyler

http://www.w3.org/2001/XMLSchema#string

P2860

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate

Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection

Jalview Version 2--a multiple sequence alignment editor and analysis workbench

Clustal W and Clustal X version 2.0

Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines

VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus

A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2

Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.

Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2

Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7

P304

4267-4274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2014.06.054

http://www.w3.org/2001/XMLSchema#string

P407

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Michelle A Ozbun

P577

2014-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24962748

http://www.w3.org/2001/XMLSchema#string

P932

4114576

http://www.w3.org/2001/XMLSchema#string